These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7749547)

  • 1. Heart failure and angiotensin-converting enzyme inhibitors: towards evidence-based health care.
    Cowie MR; Hardman SM
    Br J Hosp Med; 1995 Mar 1-14; 53(5):186-8. PubMed ID: 7749547
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic heart failure: evidence for ACE inhibitors.
    Cleland JG
    Int J Clin Pract Suppl; 1999 Dec; 108():7-10. PubMed ID: 10692721
    [No Abstract]   [Full Text] [Related]  

  • 3. Underuse of evidence-based therapies.
    Hlatky MA
    Circulation; 2004 Aug; 110(6):644-5. PubMed ID: 15302805
    [No Abstract]   [Full Text] [Related]  

  • 4. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibition of renin-angiotensin-aldosterone system: what evidence?].
    Mota T
    Rev Port Cardiol; 2001 Mar; 20 Suppl 3():13-5. PubMed ID: 11409069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitors in hypertension and congestive heart failure.
    Gavras I; Gavras H
    Adv Intern Med; 1990; 35():249-67. PubMed ID: 2405595
    [No Abstract]   [Full Text] [Related]  

  • 7. Underutilization of evidence-based therapy in heart failure. An opportunity to deal a winning hand with ace up your sleeve.
    Deedwania PC
    Arch Intern Med; 1997 Nov; 157(21):2409-12. PubMed ID: 9385293
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of angiotensin-converting enzyme inhibitors in patients with congestive heart failure. Same efficacy? Same costs?].
    González-Juanatey JR
    Med Clin (Barc); 1998 Feb; 110(7):278. PubMed ID: 9562957
    [No Abstract]   [Full Text] [Related]  

  • 9. Progress in the development of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Singh RK; Barker S
    Curr Opin Investig Drugs; 2005 Mar; 6(3):269-74. PubMed ID: 15816503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.
    Dulin BR; Krum H
    Curr Opin Cardiol; 2006 Jul; 21(4):393-9. PubMed ID: 16755210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should angiotensin receptor blockers be added to angiotensin-converting enzyme inhibitors in the treatment of heart failure?
    Ghanem FA; Movahed A
    Rev Cardiovasc Med; 2005; 6(4):206-13. PubMed ID: 16379016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter regarding article by Masoudi et al, "national patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction".
    Sabatini T; Rozzini R; Trabucchi M
    Circulation; 2005 May; 111(17):e276-7; author reply e276-7. PubMed ID: 15867189
    [No Abstract]   [Full Text] [Related]  

  • 13. [Angiotensin converting enzyme inhibitors in the treatment of heart failure].
    Bettencourt P; Ferreira A
    Rev Port Cardiol; 2000 Dec; 19 Suppl 2():II51-6. PubMed ID: 11301911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of ACE inhibitors and angiotensin receptor blockers in the treatment and prevention of chronic heart failure].
    Kárpáti P
    Orv Hetil; 2005 May; 146(18):827-31. PubMed ID: 15926627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of angiotensin-converting enzyme inhibitors in anterior infarct without congestive symptoms. The arguments pro].
    de Teresa E
    Rev Esp Cardiol; 1994 Nov; 47(11):723-8. PubMed ID: 7800901
    [No Abstract]   [Full Text] [Related]  

  • 16. [The use of angiotensin-converting enzyme inhibitors in anterior infarct without congestive symptoms. The arguments contra].
    Rodríguez Lambert JL; Moris C
    Rev Esp Cardiol; 1994 Nov; 47(11):719-22. PubMed ID: 7800900
    [No Abstract]   [Full Text] [Related]  

  • 17. Suppression of the renin-angiotensin-aldosterone system in chronic heart failure: choice of agents and clinical impact.
    Jorde UP
    Cardiol Rev; 2006; 14(2):81-7. PubMed ID: 16493245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current role of angiotensin II antagonists in the treatment of heart failure].
    Porcu M; Orrù P
    Ital Heart J Suppl; 2000 Sep; 1(9):1213-4. PubMed ID: 11140296
    [No Abstract]   [Full Text] [Related]  

  • 19. New hope from a 40-year-old drug: deaths from heart failure cut by 30 percent.
    Comarow A
    US News World Rep; 1999 Aug; 127(5):69. PubMed ID: 10539698
    [No Abstract]   [Full Text] [Related]  

  • 20. [Should cardiac insufficiency be first treated by angiotensin converting enzyme inhibitors?].
    Bareiss P; Roul G
    Arch Mal Coeur Vaiss; 1993 Feb; 86 Spec No 2():35-40. PubMed ID: 8215788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.